Can Lantus (insulin glargine) be given with Novolog 70/30 (insulin aspart protamine/insulin aspart)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lantus Should Not Be Given with Novolog 70/30

Insulin glargine (Lantus) should not be mixed with other forms of insulin, including Novolog 70/30, due to the low pH of its diluent which can affect the pharmacokinetics of other insulins. 1

Rationale for Not Mixing Lantus with Other Insulins

  • Insulin glargine has a unique formulation with an acidic pH (4.0) that is essential for its stability and prolonged action profile 2
  • When mixed with other insulins, physicochemical changes can occur that alter the pharmacokinetic properties of both insulins, potentially leading to unpredictable glucose control 1
  • The American Diabetes Association explicitly states that insulin glargine should not be mixed with other forms of insulin 1
  • The FDA label for Lantus specifically warns against diluting or mixing Lantus with any other insulin or solution 3

Proper Administration of These Insulins

  • Lantus (insulin glargine) should be administered as a separate injection once daily at the same time each day 3
  • Novolog 70/30 (insulin aspart protamine/insulin aspart) is typically administered twice daily, before breakfast and dinner 4, 5
  • When using both types of insulin in a regimen, they should be administered as separate injections 1, 3

Clinical Implications

  • Using both insulins in a regimen (but as separate injections) can provide complementary coverage:
    • Lantus provides consistent 24-hour basal insulin coverage with no pronounced peak 6
    • Novolog 70/30 provides both intermediate-acting and rapid-acting components to cover basal and prandial needs 4
  • Premixed insulins like Novolog 70/30 offer the advantage of fewer daily injections while providing both basal and prandial coverage 4, 5
  • Basal insulins like Lantus may be used in combination with premixed insulins, but must be administered separately 1

Potential Alternatives

  • If simplification of the regimen is desired, consider:
    • Using only Novolog 70/30 twice daily (before breakfast and dinner) 1, 4
    • Using Lantus once daily plus rapid-acting insulin (like regular Novolog) before meals 1
  • When switching between insulin regimens, maintain the same total daily dose initially but adjust the distribution appropriately 7
  • More frequent blood glucose monitoring is essential during any transition period between insulin regimens 7, 8

Common Pitfalls to Avoid

  • Never mix Lantus in the same syringe with any other insulin 1, 3
  • Avoid converting between insulin regimens on a 1:1 basis without considering appropriate dose adjustments 7, 8
  • Don't neglect more frequent blood glucose monitoring during transition periods between insulin regimens 7
  • Remember that meal timing becomes more critical with premixed insulins compared to basal-bolus regimens 7, 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Medication of the month. Insulin glargine (Lantus)].

Revue medicale de Liege, 2004

Research

Insulin glargine (Lantus).

International journal of clinical practice, 2002

Guideline

Insulin Regimen Conversion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Switching from NPH Insulin to 70/30 Insulin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.